Vote now for the Powering the Future: Representation in Healthcare #SXSWEDU session idea on PanelPicker! Click on the link below and we can get this important conversation with Gilead Sciences, Morehouse College and Pulse Of Perserverance on the SXSW EDU stage March 3-6, 2025.
The Artemis Agency’s Post
More Relevant Posts
-
Last day to get your conference giveaways from BCD. Grab a first-aid kit to soothe those conference walking blisters at the Diversity in Clinical Trials Summit. Continued essential conversations this morning about why representation matters to ensure health equity and how intentional collaboration promotes diverse trial participation. Honored to participate in this important event and meet the people moving the needle forward in life sciences. #clinicaltrials #lifesciences #patientengagement #patientcentricity
To view or add a comment, sign in
-
-
Beyond Convenience: How Decentralized Clinical Trials Are Empowering Patient Voices In a world where patient expectations are evolving, so must clinical trials. Decentralized Clinical Trials (DCTs) aren't just about convenience - they represent a profound shift towards empowering patients by valuing their time, comfort, and input at every stage of the research journey. Through DCTs, we're not only addressing logistical barriers but actively listening to patients’ needs, transforming their role from passive participants to true partners in research. This shift helps us reach more diverse populations and ensures that clinical research reflects real-world experiences and outcomes. Let’s keep putting patients at the center of every innovation in healthcare. 🌍💡 #DecentralizedTrials #PatientVoice #ClinicalResearch #HealthcareInnovation #DCT For getting information about our DCT activities, visit 👉 https://lnkd.in/giFeHCYj
To view or add a comment, sign in
-
-
I’m listening in to this insightful and thoughtful panel discussion from MedTech Color! I appreciate the practical strategies and case studies the panel is sharing on how to make clinical trials more inclusive and representative of the proposed patient and user population. Key takeaway so far: Designing clinical trials with a lens of inclusion and representation is a critical step for ensuring the safety and effectiveness of medical devices and other medical products. This is public health issue!
We're ONE WEEK AWAY from our "Equity in Action: Redefining FDA Clinical Trials Through Inclusive Research" webinar! This informative session will delve into the critical importance of diversity in clinical trials and how inclusive research can drive meaningful change. Our esteemed panel includes: Moderator: Dr. Candice Carpenter Panelists: Brittany Gerald-Lewis, Associate Director at Moderna Maria Restrepo, PhD, Diversity in Clinical Trials Program Director at Medtronic Dr. Nadine Spring, Assistant Professor in Public Health and Owner of Springwell360 LLC The webinar will be held on: January 31, 2025, at 10:00 am PT / 1:00 pm ET. Register: https://loom.ly/Hy_jT34 #equity #clinicaltrials #healthcare #freewebinar #medtech
To view or add a comment, sign in
-
-
“Much of the medical information we have today is based on clinical research that doesn’t include enough women and other underrepresented groups. The recommendations in this new publication provide a roadmap to ensure a more inclusive healthcare system for everyone.” — Abbott Vascular DVP Jennifer Jones-McMeans, discussing a new report she co-authored on advancing diversity in clinical trials, including strategies to improve trust, transparency and access Danielle Kirsh has more at Medical Design & Outsourcing: https://lnkd.in/gu3JUEx9
To view or add a comment, sign in
-
-
🎉 Exciting Update in Healthcare! 🎉 In a groundbreaking move, Novant Health is investing $1 million for clinical trials in partnership with UNC Health. This collaboration is set to pave the way for innovative treatments and improved patient care right here in North Carolina! 🏥 As someone who is deeply passionate about medical advancements, I see this as a significant step forward. Clinical trials are the cornerstone of developing new therapies, and this investment will likely accelerate breakthroughs in several key areas. Imagine the possibilities—new treatment options, enhanced patient outcomes, and a healthier community. By working together, Novant Health and UNC Health are setting a powerful example of how partnerships can drive positive change. It's inspiring to see such commitment to improving healthcare for everyone. 🌟 #HealthcareInnovation #ClinicalTrials #PartnershipsMatter
To view or add a comment, sign in
-
What does a leader in #ClinicalResearch look like to you? If you’re thinking wide-ranging expertise, rapid study startup and patient diversity, Alliance Clinical has all that and more. Contact us today to accelerate your study: https://lnkd.in/ghzHNtbc #ClinicalTrials #ClinicalStudies #Healthcare #PatientDiversity #AllianceClinical
To view or add a comment, sign in
-
At Superior Clinical Research, we're dedicated to making clinical trials accessible and transparent. From increasing diversity in studies to ensuring top-quality research, we're here to make a difference in healthcare. Discover what we do and why it matters! ⭐ #SuperiorClinicalResearch #ClinicalResearch #HealthcareInnovation #DiversityInResearch #MedicalResearch #ClinicalTrials #ResearchMatters #HealthcareExcellence #PatientAdvocacy #ClinicalStudy #ResearchAndDevelopment #HealthEquity #ScienceInAction #TrialTransparency #InnovativeResearch #CommunityHealth
To view or add a comment, sign in
-
At HCG, we've identified a critical challenge in the medical communications industry: effectively measuring the true impact of our work. Our recent survey reveals that many organizations struggle with this crucial aspect. It's time to move beyond isolated engagement metrics and develop comprehensive frameworks that demonstrate real value for HCPs and patients. HCG: Accelerating the Impact of Science. #HCGAccelerate #MedComms #MedCommsImpact #ImpactMeasurement #HealthcareCommunications
To view or add a comment, sign in
-
Achieving our #vision of moving #labs from a transactional relationship to a value driven business model that recognizes the #laboratory as an invaluable healthcare #asset requires engaging a broad range of stakeholders, including policy makers at the federal and state level. As such, we are pleased to announce a panel on Navigating Government Affairs during our 8th annual #PublicWorkshop in March at the Pendry Hotels & Resorts-Chicago. This session will address how to respond to the needs of the present while also #advocating for the public #policies that will support a future in which clinical labs are driving better #outcomes for patients, providers, and financial stakeholders, alike. The diverse #panel of #experts will share ideas on what it will take for us to escape the ‘challenges of the present’ and influence key government officials and agencies to assist in creating a better future. This impressive panel will be facilitated by William Morice II, MD, PhD, CEO of Mayo Clinic, and will include Nancy Stratton, CEO of COLA Inc. and Clinical Lab 2.0 Board of Directors Member, Susan Van Meter, President of American Clinical Laboratory Association, Dr. Donald Karcher, President of College of American Pathologists (CAP), and Dr. James Crawford, Professor and Chair Emeritus of Pathology and Laboratory Medicine at Northwell Health and Chair of the Clinical Lab 2.0 Board. What an exciting opportunity to hear from thought leaders about shaping the future state of #government #policy impacting laboratory #operations! You'll be able to ask questions directly of the panel as well. #Register for the #workshop today! #medicallaboratoryscience #clinicallaboratoryscience #compliance #pathology #pathologists #labdirectors #laboratorymedicine #reactiveconfirmationtoproactiveprediction #wholepersoncare
To view or add a comment, sign in
-
Putting Patients First: Our Patient-Centric Approach at Superior Clinical Research At Superior Clinical Research, we believe that the key to successful clinical trials lies in truly understanding and prioritizing the needs of our patients. One of the ways we do this is by offering flexible scheduling, including extended hours and weekend availability to accommodate the busy lives of our participants. Why is this important? By providing flexible scheduling, we reduce barriers to participation, making it easier for diverse populations to engage in clinical trials. This not only enhances the patient experience but also leads to more inclusive and comprehensive study results. We are committed to ensuring that every participant feels valued, respected, and supported throughout their journey with us. After all, clinical research is about people—improving lives and advancing healthcare for all. Interested in learning more about our patient-centric approaches? Let’s connect and discuss how we’re making a difference in clinical research!!! #PatientCentricity #ClinicalResearch #PatientCare #SuperiorClinicalResearch #HealthcareInnovation
To view or add a comment, sign in
-